Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma

Chinese Medical Sciences Journal

Volumn 19, Issue 3, 2004, Pages 199-202

  Kong, Yan Guo ^a   Ren, Zu Yuan ^a   Su, Chang Bao ^a   Wang, Ren Zhi ^a   Ma, Wen Bing ^a   Lian, Wei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Pituitary adenoma; Pituitary carcinoma; Soluble epidermal growth factor receptor

Indexed keywords

CORTICOTROPIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH HORMONE; PROLACTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CORRELATION FUNCTION; CORTICOTROPIN RELEASE; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS CARCINOMA; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; PROLACTIN RELEASE; PROTEIN BLOOD LEVEL; SERUM; TUMOR VOLUME;

ADENOMA; ADOLESCENT; ADULT; AGED; CARCINOMA; CRANIOPHARYNGIOMA; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PITUITARY APOPLEXY; PITUITARY GLAND; PITUITARY NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 5444226299     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Kong YG, Ren ZY, Su CB, et al. Detection of serum epidermal growth factor receptor in the diagnosis of proliferation of pituitary adenomas. Natl Med J China 2002;82:527-9.
2. Dahia PLM, Grossman AB. The molecular pathogenesis of corticotroph tumors. Endocr Rev 1999;20:136-55.
3. Onguru O, Scheithauer BW, Kovacs K, et al. Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor receptor expression in pituitary adenomas and carcinomas. Mod Pathol 2004;17:772-80.
4. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103:211-25.
5. Tsao AS, Herbst RS. Factors that determine response to EGFR inhibitors. Signal 2003;4:4-9.
6. Heaney AP, Melmed S. Molecular targents in pituitary tumours. Nat Rev Cancer 2004;4:285-95.
7. Sasaki H, Yukiue H, Sekimura A, et al. Elevated serum epital growth factor receptor level in stage IV thymoma. Surg Today 2004;34:477-9.
8. Sasaki H, Yukiue H, Mizuno K, et al. Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer. Intern J Clin Oncol 2003;8:79-82.
9. Baron AT, Cora EM, Lafky JM, et al. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential Risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2003;12:103-13.
10. Kong YG, Su CB, Ren ZY, et al. Measurement of soluble CD44v6 in peripheral blood as assistant diagnosis of invasive pituitary adenomas. Acta Acad Med Sin 2003;25:698-701.
11. Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 2004;59(2 Suppl):21-6.
12. Barnes CJ, Kumar R, Biology of the epidermal growth factor receptor family. Cancer Treat Res 2004;119:1-13.
13. Shimon I, Melned S. Genetic basis of endocrine disease pituitary tumor pathogenesis. J clin Endocrinol Metab 1997;82:1675-81.